TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- Citation:
- J Clin Oncol vol 29 (10) 1373-1381
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, P50 CA140158, CA140158, CA16058, CA101140, U10 CA077658, U10 CA031946, R21 CA129657, U10 CA033601, U24 CA114725, U10 CA101140, P30 CA016058, CA77658, CA129657, CA114725, CA31946
- Corr. Author:
- Authors:
- Klaus H. Metzeler Kati Maharry Michael D. Radmacher Krzysztof Mrózek Dean Margeson Heiko Becker John Curfman Kelsi B. Holland Sebastian Schwind Susan P. Whitman Yue-Zhong Wu William Blum Bayard L. Powell Thomas H. Carter Meir Wetzler Joseph O. Moore Jonathan E. Kolitz Maria R. Baer Andrew J. Carroll Richard A. Larson Michael A. Caligiuri Guido Marcucci Clara D. Bloomfield
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-8525, CALGB-10201, CALGB-19808, CALGB-20202, CALGB-20502, CALGB-8461, CALGB-8923, CALGB-9420, CALGB-9621, CALGB-9665, CALGB-9720
- Phases:
- 1, 3, N/A
- Keywords:
- Hema4, Hema9, To2, To19, Original Reports, Hematologic Malignancies